Modifiable risk factors for glioblastoma: a systematic review and meta-analysis

Imagem de Miniatura
Arquivos
art_YOSHIKAWA_Modifiable_risk_factors_for_glioblastoma_a_systematic_review_2023.PDF (1.2 MB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
Citação
NEUROSURGICAL REVIEW, v.46, n.1, article ID 143, 11p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Glioblastoma (GBM) is the most common and aggressive glioma histological subtype, associated with high disability and poor survival. The etiology of this condition is still mostly unknown, and evidence about risk factors is elusive. The aim of this study is to identify modifiable risk factors for GBM. Electronic search was performed by two reviewers independently using the keywords and MeSH terms 'glioblastoma' OR 'glioma' OR 'brain tumor' AND 'risk factor'. The inclusion criteria were (1) observational studies or experimental studies on humans, (2) studies assessing the association between glioblastoma and exposure to modifiable conditions, and (3) studies published in English or Portuguese. Studies on the pediatric population or about exposure to ionizing radiation were excluded. A total of 12 studies were included. Seven were case-control studies, and five were cohort studies. The risk factors assessed included body mass index, alcohol consumption, exposure to magnetic fields, diabetes mellitus type 2 (DM2), and use of non-steroidal anti-inflammatory drugs (NSAID). No significant link was found between GBM incidence and DM2 or magnetic field exposure. On the other hand, higher BMI, alcohol consumption, and NSAID use demonstrated a protective effect on GMB risk. However, given the limited number of studies, it is not possible to obtain a behavioral recommendation; instead, these findings are relevant to guide future basic scientific studies on GBM oncogenesis.
Palavras-chave
Glioblastoma, Brain tumor, Risk factor, Exposure
URI
https://observatorio.fm.usp.br/handle/OPI/54721
Referências
  1. Baglietto L, 2011, INT J CANCER, V128, P1929, DOI 10.1002/ijc.25770
  2. Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006
  3. Barami K, 2017, WORLD NEUROSURG, V106, P300, DOI [10.1016/j.wneu.2017.06.164, 10.1016/J.WNEU.2017.06.164]
  4. BOEING H, 1993, INT J CANCER, V53, P561, DOI 10.1002/ijc.2910530406
  5. Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741
  6. Braganza MZ, 2014, BRIT J CANCER, V110, P242, DOI 10.1038/bjc.2013.611
  7. Buccoliero AM, 2006, CLIN NEUROPATHOL, V25, P59
  8. Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079
  9. Cote DJ, 2021, EUR J EPIDEMIOL, V36, P965, DOI 10.1007/s10654-021-00800-1
  10. Daugherty SE, 2011, CANCER PREV RES, V4, P2027, DOI 10.1158/1940-6207.CAPR-11-0274
  11. de Wit MCY, 2004, NEUROLOGY, V63, P535, DOI 10.1212/01.WNL.0000133398.11870.9A
  12. Deininger MH, 1999, J NEUROIMMUNOL, V95, P202, DOI 10.1016/S0165-5728(98)00257-4
  13. Deitrich R, 2006, ALCOHOL RES HEALTH, V29, P266
  14. Disney-Hogg L, 2018, BRIT J CANCER, V118, P1020, DOI 10.1038/s41416-018-0009-x
  15. Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227
  16. Edlinger M, 2012, J HYPERTENS, V30, P290, DOI 10.1097/HJH.0b013e32834e9176
  17. Fanelli GN, 2021, GENES-BASEL, V12, DOI 10.3390/genes12030445
  18. Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015
  19. GILES GG, 1994, INT J CANCER, V59, P357, DOI 10.1002/ijc.2910590311
  20. HOCHBERG F, 1990, J NEURO-ONCOL, V8, P55
  21. Hu JF, 1999, INT J CANCER, V81, P20, DOI 10.1002/(SICI)1097-0215(19990331)81:1<20::AID-IJC4>3.0.CO;2-2
  22. Inskip PD, 1995, EPIDEMIOL REV, V17, P382
  23. Joki T, 2000, CANCER RES, V60, P4926
  24. Kabat GC, 2018, CANCER EPIDEMIOL, V54, P71, DOI 10.1016/j.canep.2018.03.008
  25. Kuan AS, 2019, NEURO-ONCOLOGY, V21, P944, DOI 10.1093/neuonc/noz013
  26. Kyrgiou M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j477
  27. Lee M, 1997, CANCER CAUSE CONTROL, V8, P13, DOI 10.1023/A:1018470802969
  28. LOSCHER W, 1994, LIFE SCI, V54, P1531, DOI 10.1016/0024-3205(94)90024-8
  29. Montemurro N, 2023, NEUROL INT, V15, P595, DOI 10.3390/neurolint15020037
  30. Montemurro N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228501
  31. Neglia JP, 2006, J NATL CANCER I, V98, P1528, DOI 10.1093/jnci/djj411
  32. Niedermaier T, 2015, NEUROLOGY, V85, P1342, DOI 10.1212/WNL.0000000000002020
  33. Ohgaki H, 2010, CURR OPIN NEUROL, V23, P583, DOI 10.1097/WCO.0b013e3283405b5f
  34. Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319
  35. Ostrom QT, 2015, NEURO-ONCOLOGY, V16, P1, DOI [10.1093/neuonc/nov189, 10.1093/neuonc/nou327, 10.1093/neuonc/nou223]
  36. Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087
  37. Ostrom QT, 2011, CURR NEUROL NEUROSCI, V11, P329, DOI 10.1007/s11910-011-0189-8
  38. Perdiki M, 2007, MOL CELL BIOCHEM, V295, P75, DOI 10.1007/s11010-006-9275-7
  39. Pignataro L, 2007, J NEUROSCI, V27, P12957, DOI 10.1523/JNEUROSCI.4142-07.2007
  40. RYAN P, 1992, INT J CANCER, V51, P20, DOI 10.1002/ijc.2910510105
  41. Scheurer ME, 2011, INT J CANCER, V129, P2290, DOI 10.1002/ijc.25883
  42. Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191
  43. Sergentanis TN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136974
  44. Shono T, 2001, CANCER RES, V61, P4375
  45. Sivak-Sears NR, 2004, AM J EPIDEMIOL, V159, P1131, DOI 10.1093/aje/kwh153
  46. THERIAULT G, 1994, AM J EPIDEMIOL, V139, P550, DOI 10.1093/oxfordjournals.aje.a117046
  47. Villeneuve PJ, 2002, INT J EPIDEMIOL, V31, P210, DOI 10.1093/ije/31.1.210
  48. Wells G., NEWCASTLE OTTAWA SCA
  49. Wiedmann M, 2013, BRIT J CANCER, V109, P289, DOI 10.1038/bjc.2013.304
  50. Wiedmann MKH, 2017, NEURO-ONCOLOGY, V19, P976, DOI 10.1093/neuonc/now272
  51. Wirsching Hans-Georg, 2016, Handb Clin Neurol, V134, P381, DOI 10.1016/B978-0-12-802997-8.00023-2

Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/62
Artigos e Materiais de Revistas Científicas - ODS/03